Abstract:ABSTRACT Metabolic syndrome (MetS) represents a cluster of major risk factors known to be associated with the development of aging-related diseases, such as cardiovascular disease and diabetes. Telomere length (TL) is often used as a cellular marker for biological age. Shorter TL indicates increased biological age. It is unknown whether maintenance of a short TL could be predictive for onset of metabolic diseases associated with increasing biological age. A number of studies found significant associations between shorter TL and dysregulated MetS components, but other studies did not confirm this finding. This cohort study investigated the relationship between shorter baseline TL and a worse metabolic profile with less favorable trajectories of MetS components over a 6-year follow-up. Participants included 2842 men and women aged 18 to 65 years who were part of The Netherlands Study of Depression and Anxiety, an ongoing prospective cohort study with 6-year follow-up. Telomere length from leukocytes was determined using quantitative polymerase chain reaction. Metabolic syndrome components (waist circumference, triglycerides, high-density lipoprotein &lsqb;HDL&rsqb;, cholesterol, fasting glucose, and systolic and diastolic blood pressure) were determined at baseline and after 2 and 6 years. Adjustments were made at baseline and 2- and 6-year follow-up for covariates (sociodemographic, lifestyle, and health factors) that could affect cross-sectional and longitudinal analyses. Shorter TL was cross-sectionally associated with a higher number of MetS abnormalities (&bgr; = 0.075, SE = 0.023, P = 0.001), higher waist circumference (&bgr; = 0.647, SE = 0.238, P = 0.007), triglycerides (&bgr; = .038, SE = 0.009, P < 0.001), and fasting glucose (&bgr; = 0.011, SE = 0.003, P < 0.001), and with lower HDL cholesterol (&bgr; = − 0.016, SE = 0.008, P = 0.05). No consistent patterns of association between TL and hypertension were found. Baseline differences progressively diminished over time; however, shorter baseline TL was still significantly associated with a worse level for most MetS components at both the 2- or 6-year follow-up. These findings show that cellular aging, as assessed by TL, is associated with a higher number of MetS abnormalities (representing a more severe metabolic risk profile) that persists even after a period of 6 years. The data suggest that a shorter TL could be predictive for the onset of various aging-related somatic diseases through its effect on metabolic alterations.

The correlation between clinical laboratory data and telomeric status of male patients with metabolic disorders and no clinical history of vascular events

17-Year Follow-Up of Association Between Telomere Length and All-Cause Mortality, Cardiovascular Mortality in Individuals with Metabolic Syndrome: Results from the NHANES Database Prospective Cohort Study

Age-related changes in subtelomeric methylation in the normal Japanese population

Telomere Shortening in Patients on Long-Term Hemodialysis.

The association of metabolic syndrome with telomere length as a marker of cellular aging: a systematic review and meta-analysis

β-cell telomere attrition in diabetes: inverse correlation between HbA1c and telomere length

Abstract 504: Telomere-based Assessment of Biological Age in Patients with Advanced Vascular Disease

Association Between Oxidative Stress and Peripheral Leukocyte Telomere Length in Patients with Premature Coronary Artery Disease

Objective assessment of the association between telomere length, a biomarker of aging, and health screening indicators: A cross-sectional study

Telomere Length as a Marker of Cellular Aging Is Associated With Prevalence and Progression of Metabolic Syndrome

Investigating the association between blood metabolites and telomere length: A mendelian randomization study

Effects of Age and Biological Age-Determining Factors on Telomere Length in Type 2 Diabetes Mellitus Patients

DNA Methylation-Based Estimator of Telomere Length

Telomere length and mitochondrial DNA copy number in bipolar disorder: identification of a subgroup of young individuals with accelerated cellular aging

Telomere length measurement as a clinical biomarker of aging and disease

Association between appendicular skeletal muscle index and leukocyte telomere length in adults: A study from National Health and Nutrition Examination Survey (NHANES) 1999–2002

Telomere Length and Biological Aging in Atherosclerosis

Shortened Leukocyte Telomere Length Is Associated With Glycemic Progression in Type 2 Diabetes: A Prospective and Mendelian Randomization Analysis

Relationship of Absolute Telomere Length With Quality of Life, Exacerbations, and Mortality in COPD

Association of telomere shortening in myocardium with heart weight gain and cause of death

Changes of telomere status with aging: An update